Does Dolutegravir Sodium And Lamivudine Interact with Metformin?
Dolutegravir Sodium And Lamivudine and Metformin have a moderate drug interaction according to U.S. FDA drug labeling data. Dolutegravir inhibits renal OCT2 and MATE1 transporters, which may increase plasma concentrations of metformin. The mechanism involves inhibition of oct2 and mate1 transporters. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Dolutegravir Sodium And Lamivudine Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Dolutegravir Sodium And Lamivudine and Metformin occurs because inhibition of oct2 and mate1 transporters. Clinically, this means dolutegravir inhibits renal oct2 and mate1 transporters, which may increase plasma concentrations of metformin. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Dolutegravir Sodium And Lamivudine and your doctor is considering prescribing Metformin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider